On September 10, 2020 Ziopharm Oncology, Inc. (Nasdaq: ZIOP), reported that Laurence Cooper, M.D., Ph.D., Chief Executive Officer of Ziopharm, is scheduled to participate in two upcoming conferences (Press release, Ziopharm, SEP 10, 2020, View Source [SID1234569923]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
H.C. Wainwright 22nd Annual Global Investment Conference
Date: Wednesday, September 16, 2020
Time: 9:00 a.m. ET (presentation)
Cantor Virtual Global Healthcare Conference
Date: Thursday, September 17, 2020
Time: 1:20 p.m. ET (fireside chat)
To access the live webcast presentations, or the subsequent archived recordings, please visit the "Investors" section of the Ziopharm website at www.ziopharm.com.